Literature DB >> 21714003

Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease.

Stefano Goldwurm, Sara Tunesi, Silvana Tesei, Michela Zini, Francesca Sironi, Paola Primignani, Corrado Magnani, Gianni Pezzoli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21714003     DOI: 10.1002/mds.23807

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  23 in total

1.  Arm swing as a potential new prodromal marker of Parkinson's disease.

Authors:  Anat Mirelman; Hagar Bernad-Elazari; Avner Thaler; Eytan Giladi-Yacobi; Tanya Gurevich; Mali Gana-Weisz; Rachel Saunders-Pullman; Deborah Raymond; Nancy Doan; Susan B Bressman; Karen S Marder; Roy N Alcalay; Ashwini K Rao; Daniela Berg; Kathrin Brockmann; Jan Aasly; Bjørg Johanne Waro; Eduardo Tolosa; Dolores Vilas; Claustre Pont-Sunyer; Avi Orr-Urtreger; Jeffrey M Hausdorff; Nir Giladi
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

2.  Nonparametric modeling and analysis of association between Huntington's disease onset and CAG repeats.

Authors:  Yanyuan Ma; Yuanjia Wang
Journal:  Stat Med       Date:  2013-09-12       Impact factor: 2.373

3.  Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry.

Authors:  Annie J Lee; Yuanjia Wang; Roy N Alcalay; Helen Mejia-Santana; Rachel Saunders-Pullman; Susan Bressman; Jean-Christophe Corvol; Alexis Brice; Suzanne Lesage; Graziella Mangone; Eduardo Tolosa; Claustre Pont-Sunyer; Dolores Vilas; Birgitt Schüle; Farah Kausar; Tatiana Foroud; Daniela Berg; Kathrin Brockmann; Stefano Goldwurm; Chiara Siri; Rosanna Asselta; Javier Ruiz-Martinez; Elisabet Mondragón; Connie Marras; Taneera Ghate; Nir Giladi; Anat Mirelman; Karen Marder
Journal:  Mov Disord       Date:  2017-06-22       Impact factor: 10.338

4.  Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.

Authors:  Karen Marder; Yuanjia Wang; Roy N Alcalay; Helen Mejia-Santana; Ming-Xin Tang; Annie Lee; Deborah Raymond; Anat Mirelman; Rachel Saunders-Pullman; Lorraine Clark; Laurie Ozelius; Avi Orr-Urtreger; Nir Giladi; Susan Bressman
Journal:  Neurology       Date:  2015-06-10       Impact factor: 9.910

5.  LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.

Authors:  Faycel Hentati; Joanne Trinh; Christina Thompson; Ekaterina Nosova; Matthew J Farrer; Jan O Aasly
Journal:  Neurology       Date:  2014-07-09       Impact factor: 9.910

6.  Interest in genetic testing in Ashkenazi Jewish Parkinson's disease patients and their unaffected relatives.

Authors:  Manisha Gupte; Roy N Alcalay; Helen Mejia-Santana; Deborah Raymond; Rachel Saunders-Pullman; Ernest Roos; Martha Orbe-Reily; Ming-X Tang; Anat Mirelman; Laurie Ozelius; Avi Orr-Urtreger; Lorraine Clark; Nir Giladi; Susan Bressman; Karen Marder
Journal:  J Genet Couns       Date:  2014-08-17       Impact factor: 2.537

7.  Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease.

Authors:  Lorraine V Kalia; Anthony E Lang; Lili-Naz Hazrati; Shinsuke Fujioka; Zbigniew K Wszolek; Dennis W Dickson; Owen A Ross; Vivianna M Van Deerlin; John Q Trojanowski; Howard I Hurtig; Roy N Alcalay; Karen S Marder; Lorraine N Clark; Carles Gaig; Eduardo Tolosa; Javier Ruiz-Martínez; Jose F Marti-Masso; Isidre Ferrer; Adolfo López de Munain; Samuel M Goldman; Birgitt Schüle; J William Langston; Jan O Aasly; Maria T Giordana; Vincenzo Bonifati; Andreas Puschmann; Margherita Canesi; Gianni Pezzoli; Andre Maues De Paula; Kazuko Hasegawa; Charles Duyckaerts; Alexis Brice; A Jon Stoessl; Connie Marras
Journal:  JAMA Neurol       Date:  2015-01       Impact factor: 18.302

8.  COMBINING ISOTONIC REGRESSION AND EM ALGORITHM TO PREDICT GENETIC RISK UNDER MONOTONICITY CONSTRAINT.

Authors:  Jing Qin; Tanya P Garcia; Yanyuan Ma; Ming-Xin Tang; Karen Marder; Yuanjia Wang
Journal:  Ann Appl Stat       Date:  2014       Impact factor: 2.083

9.  Estimation of genetic risk function with covariates in the presence of missing genotypes.

Authors:  Annie J Lee; Karen Marder; Roy N Alcalay; Helen Mejia-Santana; Avi Orr-Urtreger; Nir Giladi; Susan Bressman; Yuanjia Wang
Journal:  Stat Med       Date:  2017-06-27       Impact factor: 2.373

10.  Type II kinase inhibitors show an unexpected inhibition mode against Parkinson's disease-linked LRRK2 mutant G2019S.

Authors:  Min Liu; Samantha A Bender; Gregory D Cuny; Woody Sherman; Marcie Glicksman; Soumya S Ray
Journal:  Biochemistry       Date:  2013-03-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.